Filing Flows › Labcorp Holdings (LH) › Capital expenditures
Labcorp Holdings (LH) capital expenditures by quarter
Labcorp Holdings' capital expenditures were $152M in Q3 2026 (third quarter 2026), +15% from Q2 2026. Over the last 7 quarters it ranged from $77.9M (Q2 2025) to $152M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $152M | +15% | +42% |
| Q2 2026 | $132M | +9% | +69% |
| Q1 2026 | $121M | -2% | -4% |
| Q4 2025 | $124M | +16% | — |
| Q3 2025 | $107M | +37% | — |
| Q2 2025 | $77.9M | -38% | — |
| Q1 2025 | $126M | — | — |
Q3 2026 at a glance
Labcorp Holdings, Q3 2026: revenue $3.8B (+7% year over year), operating margin 10.6%, net earnings $263M, operating cash flow $564M. The chart follows the revenue to costs, profit and cash.
Questions
What is Labcorp Holdings' capital expenditures?
Labcorp Holdings' capital expenditures were $152M in Q3 2026 (third quarter 2026), +15% from Q2 2026.
How has Labcorp Holdings' capital expenditures changed?
Over the last 7 quarters it ranged from $77.9M (Q2 2025) to $152M (Q3 2026).